Danaher Corporation (DHR) is Reiterated by Barclays to Overweight, Lowers Price Target to $ 86

Danaher Corporation (DHR) was Reiterated by Barclays to “Overweight” while Lowering the Price Target of the company shares to $ 86 from a previous price target of $105 . Barclays advised their investors in a research report released on Jul 11, 2016.

Many Wall Street Analysts have commented on Danaher Corporation. Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016. Company shares were Reiterated by RBC Capital Mkts on May 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 99 from a previous price target of $96 .

On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.

Danaher Corporation opened for trading at $81 and hit $81.28 on the upside on Friday, eventually ending the session at $80.86, with a gain of 0.20% or 0.16 points. The heightened volatility saw the trading volume jump to 50,96,238 shares. Company has a market cap of $55,688 M.

In a different news, on May 13, 2016, Angela S Lalor (SVP, Human Resources) sold 8,392 shares at $97.77 per share price. According to the SEC, on May 9, 2016, John T Schwieters (director) sold 2,500 shares at $97.05 per share price. On Apr 29, 2016, James A Lico (Executive Vice President) sold 58,954 shares at $96.86 per share price, according to the Form-4 filing with the securities and exchange commission.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Danaher Corporation

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.